State Stem Cell Agency ICOC Finance Subcommittee Agenda 01/21/09

Jan 21, 2009
Main Location: 

CIRM
210 King Street, 3rd Floor
San Francisco, CA 94107

Additional Locations: 
CONNECT 8950 Villa La Jolla Drive Suite A124 La Jolla, CA 92037
lta Partners One Embarcadero Center 37th Floor San Francisco, CA 94111
University of California, Berkeley 200 California Hall Berkeley, CA 94720
Nuvelo, Inc. 201 Industrial Rd., Ste. 310 San Carlos, CA 94070
Klein Financial Corporation 550 California Avenue, Suite 330 Palo Alto, CA 94306
Reeve-Irvine Research Center 1105 Gillespie Neuroscience Research Facility (GNRF) 837 Health Science Road University of California at Irvine School of Medicine Irvine, CA 92697-4292
ValleyCare Health System 5575 West Las Positas Blvd. Suite 300 Pleasanton, CA 94588

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

REGULAR MEETING 01-21-09

FINANCE SUBCOMMITTEE OF THE INDEPENDENT CITIZENS

OVERSIGHT COMMITTEE

TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

 

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

 

Open Session

  1. Call to Order. 
  2. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each agenda item.  Speakers are asked to limit their testimony to three (3) minutes.]

 3.Consideration of policies and implementation plan/processes for CIRM loan program, including but not limited to the Loan Administration Policy and the role of delegated underwriters/financial service prov

          a.Response to RFI from Orix [pdf]

          b.Draft Timeline from Orix [pdf]

          c.Response to RFI from SVB [pdf]

          d.Updated Loan Administration Policy [pdf]

          e.Redline versionof updated Loan Administration Policy [pdf]

          f.Disease Team Loan Related Terms [pdf]

  4. Consideration of Stimulus Program topics.

         a. Draft Chart Summary of Proposed Stimulus Programs [pdf]

 5. Update on challenges of state finances and the impact on agency bond issues.
 6. Public Comment.                                                                                                                                                      
 7. Adjournment.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

Transcripts: 

© 2013 California Institute for Regenerative Medicine